Grover F L, Johnson R R, Marshall G, Hammermeister K E
Surgical Service, Denver Department of Veterans Affairs, Colorado 80220.
Ann Thorac Surg. 1994 Mar;57(3):559-68; discussion 568-9. doi: 10.1016/0003-4975(94)90546-0.
The internal mammary artery is frequently used as a coronary artery bypass graft conduit because of superior long-term patency. The purpose of this study was to determine if there was also an advantage to the internal mammary artery in terms of operative mortality and morbidity. The Department of Veterans Affairs Cardiac Surgery Database was reviewed for two separate time periods, April 1987 through March 1989 and October 1990 through September 1991. During these periods, 14,172 patients underwent coronary artery bypass grafting. Univariate and multivariate logistic regression analyses were used to determine preoperative variables predictive of operative mortality and morbidity, with the independent variable of use of the internal mammary artery added to previously determined indicators. The total group was analyzed in risk quartiles according to expected mortality. Univariate analysis revealed an operative mortality of 6.8% in the early period and 6.5% in the latter period for the saphenous vein groups compared with 3.7% and 3.2%, respectively, for the internal mammary artery groups (p = 0.000). Multivariate analysis revealed an odds ratio of operative death with use of the internal mammary artery graft versus use of vein grafts of 0.78 during the first period and 0.72 during the second period, reductions of 22% and 28%, respectively. There were 29% and 37% reductions in the odds of operative mortality in the highest-risk quartile group of patients using the internal mammary artery graft. The odds ratio of developing mediastinitis with one internal mammary artery graft was 1.84 (p < 0.01) in the first time period and 1.11 in the second time period (p = not significant). However, with multiple mammary bypass grafts, the odds ratios were 3.70 (p < 0.01) and 2.96 (p < 0.01) in the respective time periods. On the basis of this study, it is concluded that internal mammary artery grafts in addition to providing superior long-term patency also decreased operative mortality after adjustment for patient risk factors. Use of the mammary artery does not consistently increase operative complications with the exception of mediastinitis when both internal mammary arteries are employed.
由于长期通畅率较高,乳内动脉常被用作冠状动脉旁路移植的血管。本研究的目的是确定乳内动脉在手术死亡率和发病率方面是否也具有优势。回顾了美国退伍军人事务部心脏手术数据库的两个不同时间段,即1987年4月至1989年3月以及1990年10月至1991年9月。在此期间,14172例患者接受了冠状动脉旁路移植术。采用单因素和多因素逻辑回归分析来确定预测手术死亡率和发病率的术前变量,并将乳内动脉使用情况这一自变量添加到先前确定的指标中。根据预期死亡率将整个研究组分为四个风险四分位数进行分析。单因素分析显示,在早期,隐静脉组的手术死亡率为6.8%,后期为6.5%,而乳内动脉组分别为3.7%和3.2%(p = 0.000)。多因素分析显示,在第一个时间段,使用乳内动脉移植物与使用静脉移植物相比,手术死亡的比值比为0.78,在第二个时间段为0.72,分别降低了22%和28%。在最高风险四分位数组的患者中,使用乳内动脉移植物使手术死亡几率分别降低了29%和37%。在第一个时间段内,使用一根乳内动脉移植物发生纵隔炎的比值比为1.84(p < 0.01),在第二个时间段为1.11(p =无显著性差异)。然而,在相应时间段内,使用多根乳内动脉旁路移植物时,比值比分别为3.70(p < 0.01)和2.96(p < 0.01)。基于本研究,得出结论:乳内动脉移植物除了具有较高的长期通畅率外,在对患者风险因素进行调整后,还降低了手术死亡率。除了使用双侧乳内动脉时会增加纵隔炎外,使用乳内动脉并不会持续增加手术并发症。